Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

ClinicalTrials.gov ID: NCT00671788

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00671788. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 22, 2026, 6:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. This phase II trial is studying how well dasatinib works in treating patients with persistent or recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer.

Study identification

NCT ID
NCT00671788
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
35 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2008 (Type not available)
Primary completion
Dec 2010 (Actual)
Completion
Not listed
Last update posted
Apr 15, 2016

Started 2008

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
Saint Francis Hospital and Medical Center Hartford Connecticut 06105 —
The Hospital of Central Connecticut New Britain Connecticut 06050 —
Sarasota Memorial Hospital Sarasota Florida 34239 —
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 —
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Ozark Health Ventures LLC-Cancer Research for The Ozarks Springfield Springfield Missouri 65804 —
Washington University School of Medicine St Louis Missouri 63110 —
Stony Brook University Medical Center Stony Brook New York 11794 —
Carolinas Medical Center Charlotte North Carolina 28203 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Tulsa Cancer Institute Tulsa Oklahoma 74146 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Women and Infants Hospital Providence Rhode Island 02905 —
AnMed Health Cancer Center Anderson South Carolina 29621 —
Upstate Carolina CCOP Spartanburg South Carolina 29303 —
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 —
University of Virginia Charlottesville Virginia 22908 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00671788, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2016 · Synced Nov 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.